Treatment with a Sirt1 Activator Resveratrol Prevents Cardiomyopathy in Dystrophin-Deficient Mice

被引：0
|
作者：
Kuno, Atsushi [1 ,2 ]
Hori, Yusuke [2 ]
Sato, Tatsuya [1 ]
Kouzu, Hidemichi [1 ]
Tanno, Masaya [1 ]
Miki, Takayuki [1 ]
Horio, Yoshiyuki [2 ]
Miura, Tetsuji [1 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Dept Pharmacol, Sch Med, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2011年 / 17卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2011.06.480
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [21] Resveratrol, a SIRT1 activator, inhibits muscle fibrosis in mdx mouse
    Hori, Yusuke
    Kuno, Atsushi
    Hosoda, Ryusuke
    Horio, Yoshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 65P - 65P
  • [22] Necroptosis mediates myofibre death in dystrophin-deficient mice
    Morgan, Jennifer E.
    Prola, Alexandre
    Mariot, Virginie
    Pini, Veronica
    Meng, Jinhong
    Hourde, Christophe
    Dumonceaux, Julie
    Conti, Francesco
    Relaix, Frederic
    Authier, Francois-Jerome
    Tiret, Laurent
    Muntoni, Francesco
    Bencze, Maximilien
    NATURE COMMUNICATIONS, 2018, 9
  • [23] RESVERATROL/SRT501 Sirtuin SIRT1 Activator Treatment of Type 2 Diabetes
    Elliott, P. J.
    Walpole, S. M.
    Morelli, L.
    Lambert, P. D.
    Lunsmann, W.
    Westphal, C. H.
    Lavu, S.
    DRUGS OF THE FUTURE, 2009, 34 (04) : 291 - 295
  • [24] Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice
    Rauch, Uwe
    Shami, Annelie
    Zhang, Feng
    Carmignac, Virginie
    Durbeej, Madeleine
    Hultgardh-Nilsson, Anna
    PLOS ONE, 2012, 7 (01):
  • [25] Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice
    Hosoda, Ryusuke
    Nakashima, Ryuta
    Yano, Masaki
    Iwahara, Naotoshi
    Asakura, Seidai
    Nojima, Iyori
    Saga, Yukika
    Kunimoto, Risa
    Horio, Yoshiyuki
    Kuno, Atsushi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2023, 152 (02) : 112 - 122
  • [26] ALTERED ACETYLCHOLINE RELEASE IN THE HIPPOCAMPUS OF DYSTROPHIN-DEFICIENT MICE
    Parames, S. F.
    Coletta-Yudice, E. D.
    Nogueira, F. M.
    De Sousa, M. B. Nering
    Hayashi, M. A.
    Lima-Landman, M. T. R.
    Lapa, A. J.
    Souccar, C.
    NEUROSCIENCE, 2014, 269 : 173 - 183
  • [27] Necroptosis mediates myofibre death in dystrophin-deficient mice
    Jennifer E. Morgan
    Alexandre Prola
    Virginie Mariot
    Veronica Pini
    Jinhong Meng
    Christophe Hourde
    Julie Dumonceaux
    Francesco Conti
    Frederic Relaix
    Francois-Jerôme Authier
    Laurent Tiret
    Francesco Muntoni
    Maximilien Bencze
    Nature Communications, 9
  • [28] SIRT1, resveratrol and aging
    Rogina, Blanka
    Tissenbaum, Heidi A.
    FRONTIERS IN GENETICS, 2024, 15
  • [29] SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice
    Ma, Sai
    Feng, Jing
    Zhang, Ran
    Chen, Jiangwei
    Han, Dong
    Li, Xiang
    Yang, Bo
    Li, Xiujuan
    Fan, Miaomiao
    Li, Congye
    Tian, Zuhong
    Wang, Yabin
    Cao, Feng
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [30] Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression
    Bostick, Brian
    Yue, Yongping
    Long, Chun
    Duan, Dongsheng
    CIRCULATION RESEARCH, 2008, 102 (01) : 121 - 130
12345